SmithTJ, JanssenJAMJL. 2017. Building the case for insulin-like receptor-1 involvement in thyroid-associated ophthalmopathy. Front Endocrinol, 7:167.
3.
TsuiS, NaikV, HoaN, HwangCJ, AfifiyanNF, Sinha HikimA, GianoukakisAG, DouglasRS, SmithTJ. 2008. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol, 181:4397–4405.
4.
PritchardJ, HanR, HorstN, CruikshankWW, SmithTJ. 2003. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol, 170:6348–6354.
5.
PritchardJ, TsuiS, HorstN, CruikshankWW, SmithTJ. 2004. Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. J Immunol, 173:3564–3569.
